Delivery Order SPE2DB24D2205-SPE2DB25FDTSH

Award Date 11/5/24
Potential Completion Date 11/6/24
Potential Value $38K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of STELARA 90 MG/ML SYRINGEML medical products. The $18,460.64 fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency that supports the military's healthcare needs. The contract has an ultimate completion date of December 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,460.12 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGE syringes. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,915.88 firm-fixed-price delivery order contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of October 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division. The $33,188.36 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty medication, with a period of performance through November 27, 2024. This award is under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $4,835.77 delivery order placed under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product, with an ultimate completion date of December 2, 2022. The award is a firm fixed-price contract and was not designated with any set-aside...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $21,756.45 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of April 17, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of STELARA 90 MG/ML SYRINGE medication. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. This $38,475.01...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,337.92 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML syringe, a specialty medication. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $10,557.20 for the supply of STELARA 90 MG/ML syringes. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 21, 2024. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract...
The federal contract award is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $18,614.28 firm-fixed-price delivery order was awarded on May 24, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of May 28, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical for providing a...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDTSH
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, is for the delivery of STELARA 90 MG/ML SYRINGEML (SPE2DB24D2205|SPE2DB25FDTSH) for the Defense Logistics Agency (DLA). The $38,116.07 firm fixed-price delivery order, with an ultimate completion date of November 6, 2024, is part of a larger $999,999,999 Indefinite Delivery Contract the company holds with the DLA Troop Support Medical through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen, as the prime contractor, is responsible for delivering the specified medication to the government.

Generated 5/20/25, 1:53 PM